A 3-month lifestyle modification program resulted in weight loss and improvement in eating habits, physical activity level, and A1c in patients at risk for type 2 diabetes.
Patients who underwent Roux-en-Y gastric bypass experienced greater weight loss and slightly higher diabetes remission rates than patients who underwent sleeve gastrectomy.
No significant correlation seen for children fully or partially exposed to rotavirus vaccine vs unexposed.
Incidence of type 1, type 2 diabetes increased; rates of increase higher in racial/ethnic minorities.
Public health screening of 2- to 5-year-olds revealed an islet autoantibody prevalence of 0.31%.
The performance of a European Society of Cardiology algorithm in ruling out acute myocardial infarction without ST-elevation was comparable in patients with and without diabetes mellitus.
Menopause is linked to unfavorable health effects in women with type 2 diabetes, but older age at menarche may be associated with a decrease in these adverse effects.
Peer-delivered program tied to improvements in quality of life, physical activity, pain.
Gout incidence rate significantly reduced with SGLT2 inhibitor vs GLP-1 receptor agonist.
Telemedicine instead of office visit did not change outcomes in patients with suboptimal glycemic control.
Benefits seen for diabetes remission, weight loss, changes in metabolic parameters.
The Mediterranean Diet was ranked as the best diet overall for 2020, according to new rankings released by US News and World Report.
Consumption of 4 cups of coffee per day linked to loss of fat mass, reduction in urinary creatinine.
The approval was based on data from an active-controlled, treat-to-target trial (Onset7) that included 777 pediatric patients (aged 2 to 17 years) with type 1 diabetes.
Assessment of suicide risk as part of routine pediatric type 1 diabetes care is feasible and necessary.
Increased risk for GDM seen across all levels of prepregnancy BMI and gestational weight gain.
The American Diabetes Association (ADA) has published an update to their Standards of Medical Care in Diabetes for 2020.
Significant links persisted after adjustment for markers of nutritional quality, metabolic comorbidities.
The FDA has expanded the indication for Toujeo (insulin glargine; Sanofi) 300 Units/mL to include treatment of pediatric patients aged ≥6 years with diabetes mellitus.